Literature DB >> 15461311

Introduction to sertindole in clinical practice.

Joseph Peuskens1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15461311     DOI： 10.2165/00023210-200418002-00001

Source DB:  PubMed          Journal:  CNS Drugs        ISSN： 1172-7047            Impact factor:   5.749


× No keyword cloud information.
  19 in total

Review 1.  Detection and management of comorbidity in patients with schizophrenia.

Authors:  Alan I Green; Carla M Canuso; Mark J Brenner; Joanne D Wojcik
Journal:  Psychiatr Clin North Am       Date:  2003-03

2.  Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine.

Authors:  L V Wilton; E L Heeley; R M Pickering; S A Shakir
Journal:  J Psychopharmacol       Date:  2001-06       Impact factor: 4.153

3.  Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.

Authors:  Lars Eckardt; Günter Breithardt; Wilhelm Haverkamp
Journal:  J Pharmacol Exp Ther       Date:  2002-01       Impact factor: 4.030

4.  Prolongation of QT interval in isolated feline hearts by antipsychotic drugs.

Authors:  M D Drici; W X Wang; X K Liu; R L Woosley; D A Flockhart
Journal:  J Clin Psychopharmacol       Date:  1998-12       Impact factor: 3.153

Review 5.  Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment.

Authors:  Tonmoy Sharma; Lena Antonova
Journal:  Psychiatr Clin North Am       Date:  2003-03

Review 6.  The new and evolving pharmacotherapy of schizophrenia.

Authors:  Robin Emsley; Piet Oosthuizen
Journal:  Psychiatr Clin North Am       Date:  2003-03

7.  Schizophrenia: its etiology and impact.

Authors:  D D Miller
Journal:  Pharmacotherapy       Date:  1996 Jan-Feb       Impact factor: 4.705

8.  The acute effect of sertindole on brain 5-HT2, D2 and alpha 1 receptors (ex vivo radioreceptor binding studies).

Authors:  J Hyttel; J B Nielsen; G Nowak
Journal:  J Neural Transm Gen Sect       Date:  1992

Review 9.  Management of the negative symptoms of schizophrenia: new treatment options.

Authors:  Hans-Jürgen Möller
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 10.  Psychosocial rehabilitation and psychiatry in the care of long-term patients.

Authors:  L L Bachrach
Journal:  Am J Psychiatry       Date:  1992-11       Impact factor: 18.112
View more
  2 in total

1.  Emerging role of sertindole in the management of schizophrenia.

Authors:  Stephanie L Cincotta; Joshua S Rodefer
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

Review 2.  Sertindole : a review of its use in schizophrenia.

Authors:  David Murdoch; Gillian M Keating
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.